0001104659-15-049019.txt : 20150630
0001104659-15-049019.hdr.sgml : 20150630
20150630184704
ACCESSION NUMBER: 0001104659-15-049019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150630
DATE AS OF CHANGE: 20150630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clarus Ventures II, LLC
CENTRAL INDEX KEY: 0001431437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962726
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2200
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clarus Ventures II GP, L.P.
CENTRAL INDEX KEY: 0001431439
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962727
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2200
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clarus Lifesciences II, L.P.
CENTRAL INDEX KEY: 0001431443
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962728
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-2200
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
a4.xml
4
X0306
4
2015-06-30
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001431443
Clarus Lifesciences II, L.P.
C/O CLARUS VENTURES, LLC 101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA
02142
0
0
1
0
0001431439
Clarus Ventures II GP, L.P.
C/O CLARUS VENTURES, LLC 101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA
02142
0
0
1
0
0001431437
Clarus Ventures II, LLC
C/O CLARUS VENTURES, LLC 101 MAIN STREET
SUITE 1210
CAMBRIDGE
MA
02142
0
0
1
0
Common Stock
2015-06-30
4
C
0
1618676
A
1618676
D
Common Stock
2015-06-30
4
C
0
757117
A
2375793
D
Common Stock
2015-06-30
4
P
0
376695
12
A
2752488
D
Series A Preferred Stock
2015-06-30
4
C
0
20800000
0
D
Common Stock
1618676
0
D
Series B Preferred Stock
2015-06-30
4
C
0
9728971
0
D
Common Stock
757117
0
D
The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These shares are owned directly by Clarus Lifesciences II, L.P. ("Clarus"). Clarus Ventures II GP, L.P. (the "GPLP"), as the sole general partner of Clarus, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLP disclaims beneficial ownership of all shares held of record by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures II, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Clarus. The GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which it does not have an actual pecuniary interest.
Each of Nicholas Galakatos, Denis Henner, Robert Liptak, Nicholas Simon, Michael Steinmetz and Kurt Wheeler, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Clarus. Each of Messrs. Galakatos, Henner, Liptak, Simon, Steinmetz and Wheeler disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest.
By: /s/ Robert Liptak, Manager of Clarus Ventures II, LLC, general partner of Clarus Ventures II GP, L.P., general partner of Clarus Lifesciences II, L.P.
2015-06-30
By: /s/ Robert Liptak, Manager of Clarus Ventures II, LLC, general partner of Clarus Ventures II GP, L.P.
2015-06-30
By: /s/ Robert Liptak, Manager of Clarus Ventures II, LLC
2015-06-30